CORE 3: FUNCTIONAL OUTCOME AND SYMPTOM ASSESSMENT The primary goal of this Core (FOSAC) is to provide specialized training and quality assurance procedtires for assessing functional outcome, insight, diagnosis, and psychiatric symptoms to projects and cores within the Center. FOSAC will train raters to assess patients across 3 phases of illness in the Prodromal Project, the Aftercare Core, and the Chronic Core. FOSAC will be responsible for establishing and maintaining high levels of interrater reliability, preventing rater drift, and improving the reliability and validity of Center measures. To accomplish these goals, FOSAC will: 1) maintain well-standardized, and comprehensive training and quality assurance methods for assessing functional outcome, insight, prodromal signs, diagnosis of DSM-IV disorders, and psychiatric symptoms, 2) maintain reliability standards and criteria for certification of raters who use assessment instruments such as the CAF, MODSAS, GSRFS, SUMD-R, SCID-I, SCID-II, SIPS, BPRS, SANS, and SAPS, 3) ensure high levels of interrater reliability for trainers who will be conducting assessment procedures, and 4) expand FOSAC training videotape library to include updated training interviews. Phase 1 of training requires the rating of a minimum of 6 training videotapes and having interrater reliability calculated using the accompanying """"""""Gold Standard"""""""" consensus ratings. For categorical ratings, a minimum overall kappa is required of .80 (kappa sensitivity of .80 and kappa specificity of .80). For dimensional ratings, the trainee is required to achieve a minimum Interdass Correlation Coefficient (ICC) of .80. These requirements must be met before progressing to Phase 2 which requires thatthe rater conduct 4 """"""""live"""""""" assessments for each measure. In Phase 2, the FOSAC will formally evaluate the interviewer's ability to conduct the interview. If the requirements arenotmet, the trainee will be required to attend remediation sessions before """"""""graduating"""""""" to Phase 2. All raters will enter Phase 3, a QA Program aimed at preventing rater """"""""drift"""""""" FOSAC will collaborate with other Cores for Clinical Samples and Projects around research questions such as instrument development, method development, and improving interrater reliability.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZMH1-ERB-N)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Los Angeles
United States
Zip Code
Lee, Junghee; Nuechterlein, Keith H; Knowlton, Barbara J et al. (2018) Episodic Memory for Dynamic Social Interaction Across Phase of Illness in Schizophrenia. Schizophr Bull 44:620-630
Velthorst, Eva; Meyer, Eric C; Giuliano, Anthony J et al. (2018) Neurocognitive profiles in the prodrome to psychosis in NAPLS-1. Schizophr Res :
Chen, Qiaolin; Sugar, Catherine A; Weiss, Robert E (2018) A Bayesian confirmatory factor model for multivariate observations in the form of two-way tables of data. Stat Med 37:1696-1710
Hamilton, Holly K; Williams, Terrance J; Ventura, Joseph et al. (2018) Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia. Am J Psychiatry 175:275-283
Clayson, Peter E; Kern, Robert S; Nuechterlein, Keith H et al. (2018) Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia. Schizophr Res :
Hampton, Joya N; Trotman, Hanan D; Addington, Jean et al. (2018) The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis. Stress Health 34:591-600
Kline, Emily R; Seidman, Larry J; Cornblatt, Barbara A et al. (2018) Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. Schizophr Res 192:357-363
Fernandez, Vindia G; Asarnow, Robert; Narr, Katherine L et al. (2018) Temporal lobe thickness and verbal memory in first-degree relatives of individuals with schizophrenia. Schizophr Res 199:221-225
Woodberry, Kristen A; Seidman, Larry J; Bryant, Caitlin et al. (2018) Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort. J Clin Child Adolesc Psychol 47:69-78
Grazioplene, Rachael G; Bearden, Carrie E; Subotnik, Kenneth L et al. (2018) Connectivity-enhanced diffusion analysis reveals white matter density disruptions in first episode and chronic schizophrenia. Neuroimage Clin 18:608-616

Showing the most recent 10 out of 146 publications